Montelukast Prescribing at MCKENZIE HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
4,029
Total Quantity
105.2K
NHS Cost
£5.2K
vs National Avg
+488.4%
MCKENZIE HOUSE SURGERY prescribed 4,029 items of Montelukast over the last 12 months at a cost of £5,194 to the NHS. This is 488.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
324
Jul 2026
311
Jul 2026
349
Jul 2026
328
Jul 2026
311
Jul 2026
367
Jul 2026
322
Jul 2026
359
Jul 2026
359
Jul 2026
299
Jul 2026
338
Jul 2026
362
Prescribing Details
| Total Items | 4,029 |
|---|---|
| Total Quantity | 105,191 |
| Total NHS Cost | £5,194 |
| Presentations | 4 different forms |
| vs National Average | +488.4% |
Montelukast Prescribing Comparison
| This practice | 4,029 items |
|---|---|
| National average per practice | 685 items |
| Difference | +488.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.